Mass General Brigham Becomes Latest US Health System to Adopt Pretreatment DPYD Testing
NEW YORK – Mass General Brigham (MGB) is instituting a new policy to screen all cancer patients for genetic abnormalities that place them at risk for severe, sometimes deadly, toxicities from a widely prescribed chemotherapy. The Boston-based healthcare …